Chemistry: analytical and immunological testing – Test for named disease – body condition or organ function
Reexamination Certificate
2008-04-30
2011-10-04
Yu, Melanie J (Department: 1641)
Chemistry: analytical and immunological testing
Test for named disease, body condition or organ function
C435S007100, C436S501000
Reexamination Certificate
active
08030097
ABSTRACT:
Methods and apparatus are disclosed for the measurement of lipocalin-2 in body fluids (including but not limited to blood, serum, plasma, urine, saliva, tear, etc.) by an assay such as an immunoassay or an immunotest for (1) the prediction of risk of future cardiovascular diseases; and (2) the determination of the likelihood that certain individuals will benefit to a greater or lesser extent from the use of certain treatments designed to prevent and/or treat cardiovascular diseases.
REFERENCES:
patent: 2005/0244892 (2005-11-01), Lazar et al.
patent: 2008/0254485 (2008-10-01), Valkirs et al.
Miller et al., Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease: Diagnosis Versus Risk, Current Vascular Pharmacology, 2007, 5, pp. 15-25.
Choi et al., Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease, European Journal of Endocrinology, Feb. 1, 2008, 158, pp. 203-207.
Hraba-Renevy, Suzanne and Kress, Michel. 1989. Expression of a mouse replacement histone H3.3 gene with a highly conserved 3′ noncoding region during SV40- and polyoma-induced Go to S-phase transition.Nucleic Acids Research. 17(7):2449-2461.
Kjeldsen et al. 1993. Isolation and Primary Structure of NGAL, a Novel Protein Associated with Human Neutrophil Gelatinase.J Biol Chem. 268(14):10425-10432.
Akerstrom et al. 2000. Lipocalins: unity in diversity.Biochimica et Biophysica Acta. 1482:1-8.
Flower, Darren R. 1996. The lipocalin protein family: structure and function.Biochem J. 318:1-14.
Bratt et al. 1999. Interactions between neutrophil gelatinase-associated lipocalin and natural lipophilic ligands.Biochimica et Biophysica Acta. 1472:262-269.
Liu, Quansheng and Nilsen-Hamilton, Marit. 1995. Identification of a New Acute Phase Protein. J Biol Chem. 270(38):22565-22570.
Kratchmarova et al. 2002. A Proteomic Approach for Identification of Secreted Proteins during the Differentiation of 3T3-L1 Preadipocytes to Adipocytes.Molecular&Cellular Proteomics. 1:213-222.
Meheus et al. 1993. Identification by Microsequencing of Lipopolysaccharide-Induced Proteins Secreted by Mouse Macrophages.J Immunol. 151:1535-1547.
Jayaraman et al. 2005. Identification of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Discriminatory Marker of the Hepatocyte-Secreted Protein Response to IL-1β: a Proteomic Analysis.Biotechnol Bioeng. 91:502-515.
Mishra et al. 2005. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.Lancet. 365:1231-1238.
Mishra et al. 2003. Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury.Journal of the American Society of Nephrology. 14:2534-43.
Mishra et al. 2004. Neutrophil Gelatinase-Associated Lipocalin: A Novel Early Urinary Biomarker for Cisplatin Nephrotoxicity.American Journal of Nephrology. 24:307-15.
Reghunathan et al. 2005. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome.BMC Immunology. 6:2, 1-11.
Hemdahl et al. 2006. Expression of Neutrophil Gelatinase-Associated Lipocalin in Atherosclerosis and Myocardial Infarction.Arteriosclerosis, Thrombosis&Vascular Biology. 26(1):136-42.
Tschesche et al. 2001. The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases.European Journal of Biochemistry. 268(7):1918-28.
Xu et al. 2005. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice.Proc Natl Acad Sci U S A102(17):6086-6091.
Fujino et al. 2006. Spermatogonial Cell-mediated Activation of an IκBζ-Independent Nuclear Factor-κB Pathway in Sertoli Cells Induces Transcription of the Lipocalin-2 Gene.Mol Endocrinol20(4):904-915.
Hraba-Renevey, S. et al. 1989. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism.Oncogene. 4:601-608.
Cautherley George William Hunter
Chan Cangel Pui Yee
Lehmann Matthias
Renneberg Reinhard
Wang Yu
Counts Gary
Saliwanchik Lloyd & Eisenschenk
Versitech Limited and R & C Biogenius Limited
Yu Melanie J
LandOfFree
Lipocalin-2 as a prognostic and diagnostic marker for heart... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lipocalin-2 as a prognostic and diagnostic marker for heart..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lipocalin-2 as a prognostic and diagnostic marker for heart... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4288965